Cleared Traditional

K912937 - SR1 FREE T4 ENZYME IMMUNOASSAY

K912937 is the FDA 510(k) clearance for SR1 FREE T4 ENZYME IMMUNOASSAY by Serono-Baker Diagnostics, Inc.. It is a Class 2 Chemistry device (product code CEC) cleared through the Traditional 510(k) pathway after a 137-day FDA review.

K912937 · Serono-Baker Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1991
Decision
137d
Days
Class 2
Risk

K912937 is an FDA 510(k) clearance for the SR1 FREE T4 ENZYME IMMUNOASSAY. Classified as Radioimmunoassay, Free Thyroxine (product code CEC), Class II - Special Controls.

Submitted by Serono-Baker Diagnostics, Inc. (Allentown, US). The FDA issued a Cleared decision on November 19, 1991 after a review of 137 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1695 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Serono-Baker Diagnostics, Inc. devices

Submission Details

510(k) Number K912937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 1991
Decision Date November 19, 1991
Days to Decision 137 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d slower than avg
Panel avg: 88d · This submission: 137d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEC Radioimmunoassay, Free Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1695
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEC Radioimmunoassay, Free Thyroxine

All 65
Devices cleared under the same product code (CEC) and FDA review panel - the closest regulatory comparables to K912937.
VISTA FREE THYROXINE ASSAY
K923572 · Syva Co. · Nov 1992
KODAK AMERLITE MAB FT3 ASSAY
K922713 · Eastman Kodak Company · Oct 1992
AMERLITE MAB FT4 ASSAY
K920247 · Eastman Kodak Company · Mar 1992
AFFINITY FREE T4 TEST SYSTEM
K912698 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Oct 1991
MICROZYME(TM) FREE T4 ENZYME IMMUNOASSAY TEST
K911634 · Immunotech Corp. · Jun 1991
CIBA CORNING ACS FT4 IMMUNOASSAY
K910684 · Ciba Corning Diagnostics Corp. · May 1991